Revenue Analysis - CELG-RI
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
CELG-RI Corporation
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Eliquis
0.0% of total revenue
$4.1B
Opdivo
0.0% of total revenue
$2.1B
Orencia
0.0% of total revenue
$818.0M
Yervoy
0.0% of total revenue
$651.0M
Other Growth Brands
0.0% of total revenue
$581.0M
Reblozyl
0.0% of total revenue
$555.0M
Pomalyst/Imnovid
0.0% of total revenue
$513.0M
Breyanzi
0.0% of total revenue
$411.0M
Revlimid
0.0% of total revenue
$349.0M
Camzyos
0.0% of total revenue
$314.0M
Opdualag
0.0% of total revenue
$295.0M
Opdivo Ovantig
0.0% of total revenue
$163.0M
Other Legacy Brands
0.0% of total revenue
$156.0M
Zeposia
0.0% of total revenue
$118.0M
Sprycel
0.0% of total revenue
$73.0M
Sotyktu
0.0% of total revenue
$69.0M
Cobenfy
0.0% of total revenue
$56.0M
Abraxane
0.0% of total revenue
$50.0M
Krazati
0.0% of total revenue
$50.0M
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Abecma | Abraxane | Breyanzi | Camzyos | Cobenfy | Eliquis | Krazati | Opdivo | Opdivo Ovantig | Opdualag | Orencia | Other Growth Brands | Other Legacy Brands | Pomalyst/Imnovid | Reblozyl | Revlimid | Sotyktu | Sprycel | Yervoy | Zeposia |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/31/2026 | $0 | $50.0M | $411.0M | $314.0M | $56.0M | $4.1B | $50.0M | $2.1B | $163.0M | $295.0M | $818.0M | $581.0M | $156.0M | $513.0M | $555.0M | $349.0M | $69.0M | $73.0M | $651.0M | $118.0M |
| 12/31/2025 | $324.0M | $263.0M | $1.1B | $909.0M | $128.0M | $10.9B | $157.0M | $7.8B | $229.0M | $933.0M | $2.9B | $1.5B | $599.0M | $2.1B | $1.8B | $2.0B | $236.0M | $318.0M | $2.3B | $470.0M |
| 3/31/2025 | $103.0M | $105.0M | $263.0M | $159.0M | $27.0M | $3.6B | $48.0M | $2.3B | $9.0M | $252.0M | $770.0M | $403.0M | $199.0M | $658.0M | $478.0M | $936.0M | $55.0M | $175.0M | $624.0M | $107.0M |
| 12/31/2024 | $105.0M | $174.0M | $263.0M | $223.0M | $0 | $3.2B | $39.0M | $2.5B | $0 | $254.0M | $1.0B | $512.0M | $250.0M | $823.0M | $547.0M | $1.3B | $83.0M | $198.0M | $675.0M | $158.0M |
| 9/30/2024 | $124.0M | $253.0M | $224.0M | $156.0M | $0 | $3.0B | $34.0M | $2.4B | $0 | $233.0M | $936.0M | $433.0M | $225.0M | $898.0M | $447.0M | $1.4B | $66.0M | $290.0M | $642.0M | $147.0M |
| 6/30/2024 | $95.0M | $231.0M | $153.0M | $139.0M | $0 | $3.4B | $32.0M | $2.4B | $0 | $235.0M | $948.0M | $341.0M | $222.0M | $959.0M | $425.0M | $1.4B | $53.0M | $424.0M | $630.0M | $151.0M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Declining Segments
Geographic Regions
Declining Regions
Earnings Reports
Want to see how CELG-RI's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports